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Background: Human cytomegalovirus (HCMV) is the leading infectious cause of vision loss among congenitally
infected children. Retinal pericytes play an essential role in maintaining retinal vascular and endothelial cell
proliferation. However, the role of retinal pericytes in ocular HCMV pathogenesis is unknown.
Methods: Retinal pericytes were exposed to clinical (SBCMV) and lab strains of HCMV; infectivity was analyzed
by microscopy, immunofluorescence and qRT-PCR (reverse transcription polymerase chain reaction). Cytokine
expression was examined by Luminex assay. Recombinant HCMV-GPF was used to examine viral replication kinetics.
A Tricell culture model of the inner blood-retinal barrier (IBRB) was examined for cell type infectivity using
immunohistochemistry.
Results: Retinal pericytes expressed the biomarker neuron-glial antigen 2. Antigenic expression profiles for
several cytoskeletal, cell adhesion and inflammatory proteins were shared by both retinal and brain pericytes.
Infected pericytes showed cytomegalic cytopathology and expressed mRNAs for the major immediate protein
(MIE) and HCMV phosphorylated envelop protein 65. qRT-PCR analysis showed full lytic replication of HCMV in
retinal pericytes. Pericytes exposed to SBCMV for 9 days expressed higher levels of vascular endothelial cell
growth factor mRNA compared to controls. Luminex analysis of supernatants from SBCMV-infected retinal
pericytes had increased levels of macrophage inflammatory protein-1α, beta-2 microglobulin (B2-m), matrix
metalloproteinase-3 and -9 (MMP3/9), and lower levels of IL-6 and IL-8 compared to controls. At 24 hours post
infection, pericytes expressed higher levels of IL-8, TIMP-1 (tissue inhibitor of metalloproteinase-1), and RANTES
(regulated upon activation normal T cell-expressed and presumably secreted) but lower levels of MMP9. Time
course analysis showed that both brain and retinal pericytes were more permissive for HCMV infection than
other cellular components of the BBB (blood-brain barrier) and IBRB. Using a Tricell culture model of the IBRB
(retinal endothelial, pericytes, Müller cells), retinal pericytes were most permissive for SBCMV infection. SBCMV
infection of this IBRB Tricell mixture for 96 hours resulted in increased levels of IL-6, MMP9, and stem cell factor
with a concomitant decrease in granulocyte-macrophage colony-stimulating factor and TNF-alpha.
Conclusion: In retinal pericytes, HCMV induces proinflammatory and angiogenic cytokines. In the IBRB, pericytes
likely serve as an amplification reservoir which contributes to retinal inflammation and angiogenesis.
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Human cytomegalovirus (HCMV) is an opportunistic
pathogen that is known to cause life-threatening disease
in immunocompromised individuals such as neonates,
transplant patients and sufferers of HIV/AIDS [1]. Con-
genital HCMV infection is the major cause of birth
defects, affecting approximately 40,000 children (0.2 to
2% of all live births) in the United States each year [2-6],
and is the leading infectious cause of mental retardation
and deafness in children [7,8]. Central nervous system
(CNS) abnormalities in newborn babies can include
vision loss, mental retardation, motor deficits, seizures
and sensorineural hearing loss [9-11]. With only 10 to 15%
of children presenting with symptomatic disease at birth,
HCMV can cause long-term progressive neuropathology in
children who are asymptomatic at birth. It is estimated that
approximately 8,000 children are affected each year with
some form of neuropathology associated with congenital
HCMV infections in the United States [12]. Ophthalmic
presentations associated with HCMV-induced retinitis
have been reported [13,14]; however, HCMV dissemination
in the inner blood-retinal barrier (IBRB) remains unclear.
Retinitis due to HCMV infection, which can also result in
blindness, is the most prevalent ocular disease in individ-
uals with HIV/AIDS [15-18].
The retina and brain have the highest density of vascu-
lar pericytes in the body [19]. Alcendor et al. recently
reported that primary human brain vascular pericytes
were fully permissive for HCMV infection, were more
permissive for HCMV lytic replication compared to
brain microvascular endothelial cells (BMVEC) or
astrocytes, and could serve as amplification reservoirs
for HCMV infection and dissemination in the CNS
[20]. In addition, pericyte exposure to HCMV induced
a proinflammatory cascade that likely contributes to
neuroinflammation [20]. The eye is the outermost
extension of the CNS, and the IBRB [21,22] shares
topological similarities to the blood-brain barrier (BBB),
namely that the neurovascular unit includes retinal
pericytes, retinal microvascular endothelial cells and
Müller cells. Retinal pericytes play an essential role in
maintaining retinal vascular and endothelial cell pro-
liferation [23]. The role of retinal pericytes in HCMV-
induced ocular disease is currently unknown. It is
important to identify the role of retinal pericytes and
their contribution to HCMV infection and dissemin-
ation. To our knowledge, this is the first report to date
that investigates the infectivity of human retinal peri-
cytes for HCMV and their potential role in viral dissem-
ination in the IBRB and the concomitant implications
for HCMV-associated ocular disease. Our hypothesis
is that in vascular beds normally trafficked by HCMV
during primary infection that includes the brain and ret-
inal barriers, pericytes are the most permissive cell typewithin these vascular beds for HCMV infection and rep-
resent the cell type responsible for virus amplification
and dissemination and greatly contribute to altering
these microenvironments via the induction of proin-
flammatory and angiogenic cytokines.
Methods
Cells and viruses
The SBCMV clinical strain was obtained from Dr. Ravit
Boger (Johns Hopkins University) [20] and the HCMV-
GFP recombinant virus was obtained from Dr. Gary
Hayward (Johns Hopkins University). Acquisition of the
“SBCMV” clinical isolate of was approved by the Internal
Review Board and Ethics Committee of Johns Hopkins
University Medical Center in Baltimore, Maryland.
Primary human retinal capillary endothelial cells, retinal
pericytes, human brain microvascular endothelial cells,
human brain pericytes and human astrocytes were
obtained from Cell Systems Corporation (Kirkland,
WA, USA) and were cultivated in Pericyte Media (PM)
from ScienCell (Carlsbad, CA, USA). The human Müller
cell line MIO-M1 [24], derived from an adult retina, was
kindly provided by Dr. John Penn (Vanderbilt University
Medical Center Eye Institute). Acquisition of the MIO-M1
cell line was approved by the Internal Review Board and
Ethics Committee of Vanderbilt University Medical
Center in Nashville, Tennessee. The Retinal pericytes
were maintained at low passage in PM media. Cells
were trypsinized and plated in uncoated 100- cm2
dishes or uncoated 4.2-cm2/well glass chamber slides at
a density of 1 × 106 and 2.5 × 105 cells per dish and well,
respectively. Heat-killed SBCMV was prepared by heat-
ing the viral inoculum to 65°C for 30 minutes in a water
bath [25]. Heat-killed virus was used as a replication
control in place of UV inactivated virus. The heating
protocol for HCMV that we use is mild and is unlikely
to completely destroy the viral envelope.
Cytomegalovirus infection of retinal pericytes and RNA
isolation
Cytomegalovirus infection and RNA isolation proce-
dures have been previously described [20]. The SBCMV
clinical isolate, HCMV Towne strain, and the HCMV-
GFP recombinant virus were all cultivated in human
foreskin fibroblast (HFF) cells. Retinal pericytes were
infected at a multiplicity (moi) of 0.1, virus adsorption
was allowed for 2 to 3 hours and the infectious inocu-
lum was removed and replaced with fresh media.
Immunofluorescence
Chamber slide cultures containing either mock infected
or infected cells were washed twice with PBS, pH 7.4, air
dried, and fixed in absolute methanol for 10 minutes.
Cells were air dried for 15 minutes, hydrated in Tris
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1 hour with monoclonal antibodies diluted 1:50 in PBS,
pH 7.4. Antibodies to monitor tissue markers in unin-
fected human retinal and brain vascular pericytes included
the following from Santa Cruz Biotechnology (Santa Cruz,
CA, USA): fibronectin, vimentin, CD68, NG2 proteogly-
can, beta catenin, smooth muscle actin, vascular cell
adhesion molecule-1 (VCAM-1), vascular endothelial
cadherin (VE-cadherin), alpha 4 integrin, TNF-alpha,
and NFkB. Those antibodies obtained from Millipore
(Temecula, CA, USA) included: platelet endothelial cell
adhesion molecule-1 (PECAM-1), intercellular adhesion
molecule-1 (ICAM-1), melanoma cell adhesion molecule-
1 (MelCAM-1), endothelial-leukocyte adhesion molecule
1 (E-selectin), von Willebrand factor (VWF), and Tissue
Factor. Finally, RANTES was obtained from R&D Systems
(Minneapolis, MN, USA). All antibodies were diluted 1:50
in PBS, pH 7.4.
For HCMV infections, retinal pericytes were incubated
for 1 hour with monoclonal antibodies to HCMV major
immediate protein (MIE) at a 1:50 dilution (MIE, mAb810,
Millipore. Temecula, CA, USA), the HCMV tegument
protein pp65 (UL83) at 1:50 (Vector Laboratories,
Burlingame, CA, USA) or the HCMV late nuclear anti-
gen pp28 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA). Cells were washed 3 times with Tris saline and
then incubated at 37°C for 30 minutes with a com-
bination of secondary donkey anti-mouse IgG anti-
bodies conjugated with fluroescein isothiocyanate (FITC,
Jackson ImmunoResearch, West Grove, PA, USA) at a
1:100 dilution in PBS. Cells were washed another 3 times
in Tris saline and mounted with Vectashield mounting
media (Burlingame, CA, USA) containing 1.5 μg/ml
of 4′,6-diamidino-2-phenylindole (DAPI). Fluorescence
was photographed with a Nikon TE 2000S fluorescent
microscope (Melville, NY, USA) mounted with a charge-
coupled device (CCD) camera.
Real-time qPCR
Total RNA was extracted from SBCMV-infected retinal
pericytes, mock infected and heat-killed SBCMV (control)
using a Qiagen RNAeasy Mini Kit (Qiagen, Valencia, CA,
USA). RNA was then DNAase treated before elution from
the column according to the manufacturer’s recommen-
dations. Messenger RNA in 0.5 μg of each sample was
primed using oligo-dT and reverse transcribed with a
high capacity cDNA reverse transcription kit (Applied
Biosystems, Foster City, CA, USA). Real-time PCR was
performed as previously described [20] by using gene-
specific primers for HCMV MIE: forward 5′CCAAG
CGGGCTCTGATAACCAAGCC3′ and reverse 5′ CAGC
ACCATCCTCCTCTTCCTCTGG3′) and HCMV pp65:
forward 5′GACACAACACCGTAAAGC3′ and reverse
5′CAGCGTTCGTGTTTCC3′). For amplification ofvascular endothelial growth factor (VEGF165) we used
the following primer pairs: forward 5′ATCTTCAAGC
CATCCTGTGTCC3′ and reverse 5′CAAGGCCCAC
AGGGATTTTC3.
IBRB Tricell culture infection model
A Tricell culture infection model of the IBRB, composed
of primary human retinal microvascular endothelial cells,
retinal pericytes and Müller cells, was established in
chamber slides at a ratio of 3:1:1, respectively. The
starting cell population ratios change during growth in
culture; therefore, we consistently use these primary
cells at the same passage level and the initial cultiva-
tions are performed with media recommended by the
manufacturer. Retinal microvascular endothelial cells
were initially cultivated in complete EBM-2 media
(Lonza, Walkersville, MD, USA) and allowed to become
confluent at a cell density 2.5 x 105. Retinal pericytes were
then added and the dual mixture was then cultivated in
PM. After 48 hours, Müller cells were added to complete
the Tricell mixture growing in PM. The Tricell mixture
was then infected for 96 hours with the SBCMV clinical
isolate at a moi of 0.1. Cell supernatants were analyzed
by Luminex assay [26]. The Tricell mixture was then
stained for viability using a live/dead cell viability assay
kit (Life Technologies, Grand Island, NY, USA).
Immunohistochemistry
Dual labeled immunohistochemistry (IHC) was per-
formed as previously described [27].
A monoclonal antibody to the human retinal endothelial
cell antigenic biomarker VWF was used to stain retinal
endothelial cells. Endothelial cells were visualized in the
mixture using Vector VIP (Vector Laboratories, Burlingame,
CA, USA) as a peroxidase substrate. Antigen blocking
between the use of different substrates was performed
using an Avidin/Biotin blocking kit (Vector Laboratories,
Burlingame, CA, USA). A rabbit polyclonal antibody to the
pericyte antigenic biomarker NG2 proteogylcan (Abcam,
Cambridge, MA, USA) was used to stain retinal pericytes.
Retinal pericytes were visualized in the Tricell mixture
using Vector SG (Vector Laboratories, Burlingame, CA,
USA). A rabbit polyclonal antibody to the Müller cell
antigenic biomarker glial fibrillary acidic protein (GFAP,
Abcam, Cambridge, MA, USA) was used to stain Müller
cells. Müller cells were visualized in the mixture using
diaminobenzidine (DAB) as a peroxidase substrate (Vector
Laboratories, Burlingame, MA, USA). All labeling and
substrate preparations were performed in accordance with
the manufacturers’ recommendations.
Luminex analysis
The inflammatory cytokine analysis was performed with
200 μl of cell supernatants from mock infected, SBCMV-
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post exposure using a Luminex instrument (Luminex
Corporation, Austin, TX, USA) and a 100- plate viewer
software. The inflammatory cytokine panel (Inflammation
MAP v1.0.) was designed to measure 47 proinflammatory
and angiogenic cytokines. All specimens, standards and
controls were run in triplicate according to the manufac-
turer’s protocol. The instrument is configured to collect a
minimum of 100 beads per region [28].
Statistical analysis
Experiments presented in this study were performed
in triplicate. Mock infected, SBCMV-infected and heat-
killed SBCMV-exposed retinal pericyte cell pellets ob-
tained 9 days post infection were used for qRT-PCR.
qRT-PCR experiments were replicated three times and
normalized to glyceraldehyde 3-phosphate dehydrogen-
ase (GAPDH). A P-value of < 0.05 was considered statis-
tically significant.
Results
Expression profiles of human retinal and brain pericytes
are shared
Immunoflorescent staining confirms that normal primary
human retinal pericytes express pericyte biomarkers
(Figure 1). Retinal pericytes were shown to stain positive
for fibronectin (Figure 1A), vimentin (Figure 1B), CD68
(Figure 1C) and NG2 proteogylcan (Figure 1D). This
expression pattern was consistent with the profile we




Figure 1 Normal retinal pericyte expression markers. Immunofluoresce
of retinal pericytes staining positive for fibronectin, and retinal pericyte
All images were taken on a Nikon TE2000S microscope mounted with
4',6-diamidino-2-phenylindole (DAPI) was used to stain the nuclei blue.then compared the expression profiles of normal primary
human retinal pericytes versus brain pericytes by im-
munofluorescent staining for specific cytoskeletal, cellular
adhesion and inflammatory biomarkers (Table 1). Peri-
cytes were examined for expression of cytosketal antigenic
biomarkers (fibronectin, vimentin, beta catenin, smooth
muscle actin, NG2 proteoglycan), cellular adhesion anti-
genic biomarkers (CD68, PECAM-1, VCAM-1, ICAM-1,
MelCAM-1, E-selectin, VWF, alpha 4 integrin) and inflam-
matory biomarkers (TNF-alpha, NFkB, RANTES and
Tissue Factor). We found a high degree of similarity in the
antigenic expression profiles in human brain and retinal
pericytes for those cytoskeletal, cell adhesion and inflam-
matory biomarkers we tested (Table 1). However, we
observed a lower expression level of alpha smooth muscle
actin and a higher level of VCAM-1 in retinal pericytes
compared to brain pericytes. The staining profile of
human retinal pericytes for key antigenic biomarkers
(fibronectin, vimentin, CD68, and NG2 proteoglycan)
was similar to levels previously shown to be expressed
in human brain pericytes [20].
Retinal pericytes are fully permissive for HCMV infection
Primary retinal pericytes showed similar morphological
characteristics to those shown by brain vascular peri-
cytes, namely a long extension of the cytoplasm that
was clearly visible in sub-confluent cultures (Figure 2A)
[20]. However, when confluent they appeared fibroblastic
in appearance (Figure 2B). Using a low moi with the




nt stained images of retinal pericytes of: (A) a confluent monolayer
s staining positive for (B) vimentin, (C) CD68 and (D) NG2 proteogylcan.
a charge-coupled device (CCD) camera at a 200x magnification.







Cytoskeletal Vimentin + +
Beta catenin − −
Smooth muscle actin + +/−




Cellular adhesion ICAM-1 − −
MelCAM-1 − −
E-selectin − −
VE cadherin − −
von Willebrand factor − −
Alpha 4 integrin − −
TNF-alpha − −
Inflammation NFkB − −
RANTES − −
Tissue Factor − −
Dashes indicate a negative result for immunofluorescence staining.
Figure 2 Human cytomegalovirus (HCMV) infectivity of primary huma
subconfluent monolayer of retinal pericytes, (B) a confluent monolayer of reti
strain SBCMV. Immunofluorescence staining of SBCMV-infected retinal pericyte
protein. (F) Phase fluorescent overlay image of human retinal pericytes infecte
on a Nikon TE2000S microscope (200x magnification).
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(Figure 2C). We also demonstrated that retinal pericytes
were fully lytic for HCMV replication by expression of
HCMV MIE 1 and 2 and the late viral tegument protein
pp65/UL83 (Figures 2D and E). Infection of retinal peri-
cytes with an HCMV-US28 recombinant virus expressing
GFP showed that retinal pericytes support HCMV lytic
replication with more than 90% of cells with cytomegalic
cytopathology 6 days post infection (Figure 2F). We also
examined viral replication kinetics by monitoring the
expression of HCMV mRNA transcription by qRT-PCR
in human retinal pericytes exposed to SBCMV-infected
(clinical strain) and heat-killed virus (Figure 3A). Ten
days post infection using the SBCMV clinical isolate we
observed a > 40,000 fold and 837-fold increase in HCMV
MIE and pp65 mRNA, respectively, compared to mock
infected and heat-killed virus controls (Figure 3A). Using
the Towne strain of HCMV we examined the temporal
expression of the pp65 virion tegument protein mRNA in
infected retinal pericytes. We observed a 1-fold, a 5.1-fold,
a 122-fold and a 563-fold increase in pp65 mRNA post
infection in retinal pericytes at 24, 48, 72 hours and 5 days,
respectively (Figure 3B). The highest level of HCMV tran-
scription was observed in SBCMV-infected cells following
transcriptional amplification of the major immediate genes
MIE (IE1, IE2) [29] and the viral pp65 late tegumentn retinal pericytes. Phase contrast images of (A) an uninfected
nal pericytes and (C) pericytes 10 days after infection with the clinical
s for (D) major immediate protein (MIE) protein and (E) pp65 late stage
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Figure 3 Human cytmegalovirus (HCMV) replication kinetics in human retinal pericytes. (A) Expression of HCMV mRNA by qRT-PCR in
human retinal pericytes exposed to SBCMV-infected and heat-killed virus compared to mock infected controls. Human retinal pericytes were
exposed to a human primary clinical isolate of HCMV, designated ‘SBCMV’, for 10 days. Total RNA was extracted from infected cells followed by
cDNA amplification and qRT-PCR. (B) qRT-PCR was performed using mRNA from human retinal pericytes exposed to the Towne strain of HCMV
after 24, 48, 72 hours and 5 days postinfection for the HCMV pp65 late protein mRNA transcripts. Fold expression was normalized to glyceraldehyde
3-phosphate dehydrogenase (GAPDH). Error bars represent the standard error of the mean (SEM) on triplicate experiments.
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tion were observed compared to pp65 expression levels.
No significant virus transcripts were observed in mock
or heat-killed-exposed retinal pericytes (Figure 3A). Time
course analysis of HCMV infection using the Towne strain
of HCMV revealed a time-dependent increase in pp65
transcription consistent with permissive replication for
cytomegalovirus (Figure 3B).
Cellular dysregulation of angiogenic and proinflammatory
cytokines in SBCMV-infected retinal pericytes
The majority of retinal vasculopathies are associated
with dysregulation of angiogenesis and inflammation
[28]. We examined SBCMV-infected human retinal peri-
cytes along with mock infected cells and cells exposed to
heat-killed virus for changes in vascular endothelial cellgrowth factor (VEGF) expression (Figure 4). We observe
a 2.8-fold increase in VEGF165 mRNA expression by
qRT-PCR in SBCMV-infected cells when compared to
mock infected and heat-killed virus-exposed human
retinal pericytes. We also observed a marginal but insig-
nificant increase in VEGF165 in pericytes exposed to
heat-killed virus (Figure 4). Transcription analysis using
VEGF primers that recognized all of the major three
splice variants were observed to be upregulated in
SBCMV-infected pericytes compared to uninfected con-
trol cells (data not shown). We then made a comparative
analysis using Luminex assays of 9-day supernatants
from the above mentioned cells that exhibited evidence
of cytopathology (Figure 5). We observed a high level
of MIP-1α secretion by retinal pericytes exposed to both
SBCMV and to heat-killed virus compared to mock
Figure 4 SBCMV induction of vascular endothelial cell growth
factor (VEGF) in human retinal pericytes. Expression of VEGF165
mRNA by qRT-PCR in human retinal pericytes exposed to SBCMVinfected
and heat-killed virus. Human pericytes were exposed to a human primary
clinical isolate of HCMV, designated ‘SBCMV’ for 5 days. Total RNA
was extracted from infected cells, followed by cDNA amplification
and qRT-PCR. Fold expression was normalized to glyceraldehyde
3-dehydrogenase (GAPDH). Experiments were performed in triplicate
and error bars represent the standard error of the mean (SEM). A
P < 0.05 was considered significant.
Figure 5 SBCMV induction of proinflammatory and angiogenic cytoki
Luminex analysis at 9 days post infection are given. Results from cells expo
SBCMV are shown as red bars and results from cells exposed to the SBCMV
(A) MIP-1α , (B) B2-m, (C) MMP3, (D) MMP9, (E) IL-6 and (F) IL-8. Results ar
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secretion was observed in pericytes exposed to replica-
tion competent virus. High levels of B2-m were observed
in supernatants from pericytes exposed to SBCMV and
heat-killed virus compared to uninfected cells (Figure 5B),
although the highest level of B2-m was observed in
SBCMV-infected pericytes. Increased levels of MMP3 and
MMP9 were observed in both 9-day SBCMV-infected and
SBCMV heat-killed-exposed pericytes compared to unin-
fected controls (Figure 5C and D), although levels in
SBCMV-treated cells were higher than cells exposed
to heat-killed virus. However, we observed reduced levels
of the proinflammatory cytokines IL-6 and IL-8 in both
SBCMV-infected and SBCMV heat-killed-exposed peri-
cytes compared to uninfected controls (Figure 5E and F),
with the greatest reduction occurring in heat-killed virus
exposed cultures.
At an earlier time point (24 hours post infection)
we found no significant change in B2-m, MMP3, or IL-6
levels (Figure 6A, B, and D). We observed a decreased
level of MMP9 in SBCMV-infected and heat-killed
virus-exposed retinal pericytes compared to mock in-
fected controls (Figure 6C). There was increase in IL-8,
tissue inhibitor of mealloproteinase-1 (TIMP-1), and
RANTES in SBCMV-infected retinal pericytes comparednes at 9 days. Cytokine profiles of SBCMV-infected pericytes by
sed to media only are shown as blue bars, cells exposed to heat-killed
clinical isolate are shown as green bars. Results are included for



























































































































Figure 6 SBCMV induction of proinflammatory and angiogenic cytokines at 24 hours. Cytokine profiles of SBCMV-infected pericytes (only)
by Luminex analysis at 24 hours post infection are given. Results from cells exposed to media only are shown as solid black bars, cells exposed to
heat-killed SBCMV are shown as gray bars and results from cells exposed to the SBCMV clinical isolate are shown as stippled black bars. Results
are included for (A) B2-m, (B) MMP3, (C) MMP9, (D) IL-6 (E) IL-8, (F) TIMP-1, and (G) RANTES. Results are given in pg/ml. Results shown are the
averages of triplicate samples.
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observed a greater increase in IL-8 in heat-killed virus-
exposed retinal pericytes compared to SBCMV-infected
pericytes but a greater increase in RANTES in super-
natants from SBCMV-infected pericytes compared to
heat-killed virus-exposed retinal pericytes (Figure 6E
and G). MIP-1α levels were undetectable at 24 hours in
supernatants from SBCMV-infected and heat-killed
virus-exposed retinal pericytes.Pericytes from human brain and retina are more
permissive for HCMV than other cellular components of
the BBB and the IBRB
Cellular components of the human IBRB (includes retinal
microvascular endothelial cells, retinal pericytes and
Müller cells) as well as the cellular components of the
human BBB (includes brain microvascular endothelial
cells, vascular pericytes and astrocytes) were compared to
determine their infectivity when exposed to a recombinant
Wilkerson et al. Journal of Neuroinflammation  (2015) 12:2 Page 9 of 16HCMV isolate encoding GFP. Individual cell types of both
the IBRB and the BBB were infected with a moi of 0.1 to
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Figure 7 Time course analysis of human cytomegalovirus-GFP (HCMV
panel: phase contrast images of human mock and infected retinal microva
phase contrast images of infected retinal microvascular endothelial cells, re
HCMV-GFP-positive cells. Magnification = 200x. (B) A graph showing the nu
cells (open bars), retinal pericytes (gray bars) and Müller cells (black bars) p
post infection.as controls. Infections were performed in triplicate in
chamber slides for 12, 24, 48 and 96 hours post infection











-GFP) infection of IBRB (inner blood-retinal barrier) cells. (A) Top
scular endothelial cells, retinal pericytes and Müller cells. Bottom panel:
tinal pericytes and Müller cells with a fluorescent overlay showing
mber of infected HCMV-GFP-positive retinal microvascular endothelial
er 4 × 106 total cells over the time course of 12, 24, 48 and 96 hours
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positive cells were observed after 12 hours for the individ-
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Figure 8 Time course analysis of human cytomegalovius-GFP (HCMV-
purposes, (A) the top panel includes phase contrast images of human moc
pericytes and astrocytes. The bottom panel shows phase contrast images o
astrocytes with a fluorescent overlay showing HCMV-GFP-positive cells. Tot
HCMV-GFP-positive brain microvascular endothelial cells (open bars), brain
cells over the time course 12, 24, 48 and 96 hours post infection.had a 74-fold, 160-fold, more than 300-fold and nearly a
400-fold increase in GFP-positive cells compared to








8 1 9 4
GFP) infection of BBB (blood-brain barrier) cells. For comparison
k and infected brain microvascular endothelial cells, brain vascular
f infected brain microvascular endothelial cells, brain pericytes and
al magnification is 200x. (B) A graph indicating the number of infected
pericytes (gray bars) and astrocytes (black bars) per 1.25 × 106 total
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ivity for the IBRB cell types at 10 days post infection (data
not shown). Similar results were observed with cellular
components of BBB showing brain pericytes as being
more permissive for HCMV infection when compared to
human brain microvascular endothelial cells or astrocytes
(Figure 8A and B). No GFP-positive cells were observed
after 12 hours for BBB cells, but at 24, 48, 72 and 96 hours,
pericyte cultures had a roughly 90-fold, 140-fold, 325-fold
and nearly 400-fold increase in GFP-positive cells, respect-
ively, compared to brain microvascular endothelial cells or
astrocytes (Figure 8A and B). Brain microvascular endo-
thelial cells were consistently more permissive for HCMV
than astrocytes or endothelial cells in this assay. We ob-
served no significant difference in this pattern of infectiv-
ity for the IBRB cell types at 10 days post infection (data
not shown).
In a Tricell culture infection model, retinal pericytes are
more permissive for SBCMV infection than retinal
microvascular endothelial cells and Müller cells
Over time we have observed that PM from ScienCell
can support the growth of human brain vascular peri-
cytes, astrocytes, and brain microvascular endothelial
cells, making it an ideal starting point for a universal
medium to cultivate the Tricell mixture of human retinal
pericytes, retinal capillary endothelial cells (Cell Systems,
Kirkland, WA, USA), and primary human Müller cells.
We showed that retinal capillary endothelial cells can be
cultivated in PM along with retinal pericytes and that
the Müller cell line can also be cultivated in PM media
(Figure 9A). We found that the Tricell mixed retinal cul-
ture had a > 95% viability after 10 days in culture with
PM media (Figure 9B). Validation of the Tricell IBRB
model was achieved by co-cultivation of the cell mixture,
with triple stained IHC for VWF for retinal capillary
endothelial cells, NG2 proteoglycan (neuron-glial anti-
gen2) for retinal pericytes, and GFAP glial fibrillary
acidic protein for Müller cells (Figure 9C). Supernatants
from the Tricell mixed culture exposed to SBCMV, heat-
killed virus and media only (mock infected) were alsoFigure 9 A retinal Tricell culture model. (A) Phase contrast image of a T
pericytes and Müller cells representing the inner blood-retinal barrier (IBRB)
immunohistochemistry (IHC) of the IBRB cell culture (arrows indicate an enexamined by Luminex analysis at 96 hours post infection
(Figure 10). We observed a higher level of MIP-1α,
MMP9, IL-6 and stem cell factor (SCF-1), no change in
MMP3 levels and a lower levels of IL-8, GMCSF and
TNF-alpha in SBCMV-infected Tricell cultures com-
pared to mock infected controls (Figure 10). In Tricell
cultures exposed to heat-killed virus we observe in-
creased levels of MIP-1α, IL-6, SCF-1, and TNF-alpha,
no change in MMP9, and a lower level of IL-8 when
compared to mock infected control cultures. In addition,
Tricell cultures exposed to heat-killed virus showed
higher levels of IL-8, GMCSF and TNF-alpha compared
to Tricell cultures exposed to SBCMV.
The Tricell mixture was cultivated in chamber slides,
then infected for 96 hours with SBCMV and separately
stained pairwise for both MIE or pp28, and the cell-
specific markers noted above. Cells co-stained for MIE
or pp28 and the respective IBRB cell type-specific
markers were counted and the results are shown in
Table 2. Both MIE and pp28 co-stained with IBRB
cell-specific markers revealed that there was a 10-fold
increase in retinal pericyte infectivity for HCMV infec-
tion when compared to retinal microvascular endothe-
lial cells and Müller cells (Table 2).
Discussion
The expression profiles of normal human brain and ret-
inal pericytes are shared with respect to several cytoskel-
etal, cellular adhesion and proinflammatory biomarkers.
This suggests that pericytes from different vascular beds
within the CNS are similar and that their physiology
may be governed by their respective microenvironments.
We found that brain and retinal pericytes were equally
permissive for HCMV lytic replication by both labora-
tory adapted and clinical strains of virus. In IBRB, retinal
pericytes were most permissive for HCMV infection
when compared to retinal microvascular endothelial
cells and Müller cells. HCMV infection elicited an angio-
genic and proinflammatory cytokine response in peri-
cytes after infection. From these studies we proposed a
disease model (Figure 11) for HCMV disseminationricell culture mixture of human retinal microvascular endothelial cells,
. (B) A live/dead stain of the retinal Tricell culture. (C) Triple labeled

















































































































































Figure 10 SBCMV induction of proinflammatory and angiogenic cytokines in the inner blood-retinal barrier (IBRB) Tricell culture.
Cytokine profiles of SBCMV-infected pericytes by Luminex analysis at 96 hours post infection are given. Results from cells exposed to media only
are shown as solid black bars, cells exposed to heat-killed SBCMV are shown as gray bars and results from cells exposed to the SBCMV clinical
isolate are shown as stippled black bars. Results are included for (A) MIP-1α, (B) MMP3, (C) MMP9, (D) IL-6, and (E) IL-8 (F) SCF-1, (G) GMCSF and
(H) TNF-alpha. Results are given in pg/ml. Results shown are the averages of triplicate samples.
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model we proposed for HCMV dissemination across
the BBB into the brain [20]. Our working model is that
as HCMV traffics the IBRB initially, there is marginal
infection of retinal microvascular endothelial cells that
poorly supports dissemination of the virus into the
barrier. However, HCMV-infected mononuclear cells in
the retinal vasculature may gain access through theIBRB via chemotactic signaling by the expression of
monocyte chemotactic protein-1 (MCP-1) (Figure 11A).
Cell free virus may breach the inner retinal barrier via
pinocytosis or paracellular transport. Initial infection of
retinal pericytes in a short time period results in a more
robust infection (Figure 7) compared to retinal endothelial
cells and Müller cells, which results in viral dissemination
within the barrier (Figure 9). Pericytes then serve as an
Table 2 Human cytomegalovirus (HCMV)-infected cells in a Tricell retinal model expressing cell type-specific antigenic
biomarkers
Cells Total MIE(+) cells per 30 fields (200 x) Total cells stained for specific marker Total not stained with specific marker
Retinal EC 69 5 VWF+ 64
Retinal pericytes 86 80 NG2+ 6
Müller cells 68 7 GFAP+ 61
Cells Total pp28 (+) cells per 30 fields (200x) Total stained for specific marker Total not stained with specific marker
Retinal EC 78 4 VWF+ 74
Retinal pericytes 89 84 NG2+ 5
Müller cells 93 7 GFAP+ 86
Abbreviations: EC endothelial cells, GFAP glial fibrillary acidic protein, MIE major immediate protein, NG2 neuron-glial antigen 2, VWF von Willebrand factor.
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tissue. Upon infection, retinal pericytes elicit the angio-
genic cytokine VEGF that would likely contribute to ret-
inal angiogenesis and support retinal neovascularization
[31-34]. Macrophage inflammatory protein-1 (MIP-1α/
CCL3), which was highly expressed in our retinal pericytes
after infection, would serve to heighten the inflammatory
microenvironment to establish a persistent inflammatory
state (Figure 11A). MIP-1α secretion would be chemotac-
tic for monocytes, lymphocytes, and natural killer (NK)
cells [35]. MIP-1α has been shown to be induced after
HCMV infection and is essential for NK cell migration
and IFN-gamma production to mediate antiviral responses
in infected cells [36]. High levels of MIP-1α have been
observed in gingival fibroblasts infected with HCMV and
are thought to play a role in viral pathogenesis linking
HCMV infection to periodontal disease [37]. Increased
levels of MIP-1α have also been observed in HCMV
pulmonary disease in lung transplant patients and have
been associated with decreased survival in lung transplant
recipients [38]. In addition, an increased level of MIP-1α
was observed in blood from HCMV-infected renal trans-
plant patients, a finding that positively correlated with
pp65 antigenemia, which was shown to be abrogated
by ganciclovir therapy [35]. We observed high levels of
beta-2microglobulin (B2m) expression in 9-day HCMV-
infected retinal pericytes. In a number of studies, B2-m
levels have been shown to have a predictive value for
HCMV congenital disease and have been used as a bio-
marker for fetal distress [39]. Levels of B2-m in cerebro-
spinal fluid along with neuroimaging have been shown to
be of prognostic value for neurodevelopmental outcomes
in newborns with HCMV-induced congenital disease [40].
High levels of B2-m in fetal blood were also found to be
an important prognostic marker of symptomatic HCMV-
induced congenital disease [41]. We also found an in-
crease in the secretion of MMP3 and MMP9 at 9 days
post HCMV infection that we propose would aid the virus
in tissue dissemination from infected pericytes as it traffics
through the inner retinal barrier. HCMV has been shown
to induce MMP1 and MMP3 in human aortic smoothmuscle cells, which has implications for HCMV-induced
plaque inflammation in atherosclerotic disease [42]. Tear
MMP9 levels have been shown to be a marker for diag-
nosing dry eye and ocular surface disease due to inflam-
mation; thus, tear analysis may serve as a gauge to
monitor therapy after eye surgery [43,44]. Surprisingly, we
observed a lower level of IL-6 and IL-8 in supernatants of
9-day SBCMV-infected pericytes compared to uninfected
controls. This is likely due to viral-specific suppression
during late-stage infection that would be consistent with
chronic HCMV disease. It is has been reported that IL-6
levels are suppressed during active infection in human fi-
broblasts via transcriptional activation in part by HCMV
IE2 protein and posttranscriptional destabilization of IL-6
mRNA [45]. Suppressive effects outweighed transcrip-
tional activation that resulted in less IL-6 production in
cells undergoing productive infection compared to con-
trols [45]. In contrast, Luminex analysis of retinal pericytes
exposed to SBCMV at the earlier 24 hour time point, re-
vealed increases in IL-8, TIMP-1 and RANTES compared
to media only. A significant decrease in MMP9 was ob-
served compared to media controls; however, this is likely
due to the increased levels of TIMP-1. We also observed a
greater increase in IL-8 in supernatants from retinal peri-
cytes exposed to heat-killed virus at 24 hours compared to
SBCMV and media-only-exposed cells. This may be due
to virus-specific gene effects on IL-8 expression. Finally,
exposure of the Tricell mixed culture to virus for 96 hours,
a time of heightened virus replication, revealed a signifi-
cant increase in the secretion of IL-6 and SCF-1, lower
levels of granulocyte-macrophage colony-stimulating
factor (GMCSF) and TNF-alpha and a marked increase
in MMP9 (Figure 10, 11B). Studies show that a product-
ive HCMV infection reduced MMP9 activity in human
macrophages, a finding that was associated with imme-
diate early or early gene expression of HCMV [46]. It
has been demonstrated that cmvIL10 inhibited NFkB
activation via a reduced degradation of IkappaB-alpha
resulting in a decrease in transcription of NFkB respon-
sive genes TNF-alpha and IL-1beta [47]. The decrease
in TNF-alpha levels was observed in supernatants from
Figure 11 Working disease models of human cytomegalovirus (HCMV) dissemination across the inner blood-retinal barrier (IBRB). The
models include infected retinal pericytes and a HCMV-induced angiogenic and proinflammatory cascade at late-stage infection (A); Infected Tricell
mixture and HCMV-induced dysregulation of angiogenic and proinflammatory cytokines at late-stage infection (B).
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alpha are observed in pericytes exposed to heat-killed
virus that would not express vcmvIL-10 (Figure 10H).
Matlaf et al., have shown that the HCMV pp71/UL82protein expressed in human glioblastoma promotes
proangiogenic signaling by induction of SCF-1 and that
overexpression of pp71 in glial cells also results in
an increased expression of SCF-1 [48]. Carleir et al.,
Wilkerson et al. Journal of Neuroinflammation  (2015) 12:2 Page 15 of 16observed both an increase in IL-6 and a concomitant
decrease in the expression of GMCSF in dendritic cells
derived from HCMV-infected monocytes [49]. They
showed that GMCSF signaling was impaired along with
a decrease in the phosphorylation of signal transducer
and activator of transcription 5 (STAT-5). These cells
were unable to stimulate TH1 differentiation and prolif-
eration due to the increased levels of IL-6 that were
required for suppressor of cytokine signalling 3 (SOCS3)
signaling [49].
Conclusion
Taken together these studies support the notion that
HCMV infection of retinal pericytes is a lytic infection
that would result in pericyte loss at proximal sites within
the IBRB. This would have implications for retinal neu-
rovascular permeability, and would support an increase
in retinal inflammation and angiogenesis. Pericytes
appear to be the most permissive cell type within the
brain and the inner retinal neurovascular bed that is
trafficked by HCMV. Thus, therapeutic modalities
designed to specifically protect pericytes from infec-
tion could limit HCMV-induced clinical CNS disease.
The Tricell culture infection model of the IBRB also
has implications for other retinal vasculopathies. An
association was previously observed between high
HCMV IgG titers and neovascular age-related macular
degeneration (AMD), compared to both the dry form
of AMD and control subjects [50]. It has been sug-
gested that chronic HCMV infection could be a novel
risk factor for the progression from the dry form of
AMD to the neovascular or wet form of AMD [50].
Development of novel biological systems that closely
mimic the IBRB is essential, as systemic therapies for
retinal diseases are highly restricted by the IBRB.
Hence it is necessary to develop IBRB model systems
to better understand the mechanisms involved in pro-
gressive retinopathies and to provide more efficient
methods for a timely evaluation of systemic therapies
that must circumvent the IBRB [20].
Consent (Adult)
Written informed consent was obtained from the patient
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images and is compliant with standard IRB protocol.
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